Catalyst Pharmaceutical Partners, Inc. (NASDAQ:CPRX)
CAPS Rating:
A development-stage pharmaceutical company focused on the acquisition, development and commercialization of prescription drugs for the treatment of drug addiction.
RSS Headlines
Fool UK
Recs
more upsdie forthcoming